Research does not end
Article Abstract:
AstraZeneca (Sweden/UK), pharmaceutical company, plans to go on with the research and development of new drugs in the Czech Republic in 1999. Astra (Sweden) and Zeneca (UK), which set up the firm as a merger in 1999, invested more than 100 mil Kc in research and development in the Czech Republic in 1998. Despite overall decline in the local economy, AstraZeneca wants to raise its share on the Czech market in 1999. Astra alone saw sales of 460 mil Kc in the Czech Republic in 1998. AstraZeneca is the second largest pharmaceutical company in Europe and one of the five largest worldwide.
Publication Name: Ekonom-Tydenik Hospodarskych Novin
Subject: Business, international
ISSN:
Year: 1999
User Contributions:
Comment about this article or add new information about this topic:
The Cambridge Diet
Article Abstract:
An interview with stock analysts Ray Kurtz and John Tozzi, heads of the Cambridge capital investment management firm, is presented. Cambridge favors consumer and capital-goods stocks over high technology stocks. Stocks Cambridge favors include Scientific Computers, Jeffrey Martin, Alco Standard, Kysor International, James River, and Fruehauf. Tozzi and Kurtz also like Chrysler and Ford, along with oil exploration firm Woods Petroleum. Some stocks Cambridge treasures as undervalued assets include Bell & Howell, National Education Corp. and Freedom Savings & Loan.
Publication Name: Barron's
Subject: Business, general
ISSN: 1077-8039
Year: 1983
User Contributions:
Comment about this article or add new information about this topic:
Cop 3038 - a true high frequency performer
Article Abstract:
The super-fast 30 kW hydraulic rock drill COP 3038 launched by Atlas Copco is a major step in new product development, which has proved to drill amazingly 50% faster than its predecessor COP 1838 ME.
Publication Name: World Tunnelling
Subject: Construction and materials industries
ISSN: 0956-8700
Year: 2004
User Contributions:
Comment about this article or add new information about this topic: